NDC 74528-020

BYLVAY

Odevixibat

BYLVAY is a Oral Capsule, Coated Pellets in the Human Prescription Drug category. It is labeled and distributed by Albireo Pharma, Inc.. The primary component is Odevixibat.

• Product ID: 74528-020_16dd4a78-9875-4c90-9dee-8f4d6af2e710
• NDC: 74528-020
• Product Type: Human Prescription Drug
• Proprietary Name: BYLVAY
• Generic Name: Odevixibat
• Dosage Form: Capsule, Coated Pellets
• Route of Administration: ORAL
• Marketing Start Date: 2021-07-20
• Marketing Category: NDA /
• Application Number: NDA215498
• Labeler Name: Albireo Pharma, Inc.
• Substance Name: ODEVIXIBAT
• Active Ingredient Strength: 200 ug/1
• Pharm Classes: Ileal Bile Acid Transporter Inhibitor [EPC], Ileal Bile Acid Transporter Inhibitors [MoA]
• NDC Exclude Flag: N
• Listing Certified Through: 2023-12-31

Packaging

NDC 74528-020-01

1 BOTTLE in 1 CARTON (74528-020-01) > 30 CAPSULE, COATED PELLETS in 1 BOTTLE

• Marketing Start Date: 2021-07-20
• NDC Exclude Flag: N
• Sample Package?: N

Drug Details

NDC Crossover Matching brand name "BYLVAY" or generic name "Odevixibat"

NDC	Brand Name	Generic Name
74528-020	BYLVAY	odevixibat
74528-040	BYLVAY	odevixibat
74528-060	BYLVAY	odevixibat
74528-120	BYLVAY	odevixibat